Organicell Regenerative Medicine (OTCMKTS:BPSR) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.17 and traded as low as $1.66. Organicell Regenerative Medicine shares last traded at $1.68, with a volume of 2,069 shares.

Organicell Regenerative Medicine Trading Down 2.3%

The stock’s 50-day moving average is $1.92 and its two-hundred day moving average is $2.17.

Organicell Regenerative Medicine Company Profile

Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal‐like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.

The company’s pipeline is anchored by exosome‐centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.